Research and Markets: Respiratory Tract Infections - Pipeline Review, H2 2012 Features Giants such as Merck & Co., Inc., Bayer AG and Novartis AG

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/nbjhs5/respiratory_tract) has announced the addition of Global Markets Direct's new report "Respiratory Tract Infections - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Respiratory Tract Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Respiratory Tract Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Respiratory Tract Infections. Respiratory Tract Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Respiratory Tract Infections.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Respiratory Tract Infections pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

- Aradigm Corporation

- Shionogi & Co., Ltd.

- Sanofi-Aventis

- GlaxoSmithKline plc

- Daiichi Sankyo Company, Ltd

- Taisho Pharmaceutical Co., Ltd.

- Takeda Pharmaceutical Company Limited

- Nanotherapeutics, Inc.

- Rib-X Pharmaceuticals, Inc.

- Nippon Shinyaku Co., Ltd.

- Zosano Pharma, Inc.

- Insmed Incorporated

- Dongwha Pharm Co., Ltd.

- Green Cross Corporation

- iBio, Inc.

- Tetraphase Pharmaceuticals Inc.

- Afexa Life Sciences Inc.

For more information visit http://www.researchandmarkets.com/research/nbjhs5/respiratory_tract

Source: Global Markets Direct

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Respiratory

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Respiratory